Roger N. Farah - 15 Nov 2023 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
Director
Signature
/s/ Roger N. Farah
Issuer symbol
CVS
Transactions as of
15 Nov 2023
Net transactions value
+$305,000
Form type
4
Filing time
17 Nov 2023, 16:47:40 UTC
Previous filing
17 Oct 2023
Next filing
30 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CVS Common Stock 4,041 15 Nov 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Share Credits Award $305,000 +4,412 +17% $69.13 29,639 15 Nov 2023 Common Stock 4,412 $0.000000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.
F2 Consists of deferred stock compensation payable pursuant to Reporting Person's election.